41 results
8-K
EX-1.1
VERV
Verve Therapeutics Inc
29 Nov 23
Verve Therapeutics Announces Pricing of Public Offering of Common Stock and Concurrent Private Placement
4:54pm
of the products or services of the Company) by the Federal Trade Commission, the U.S. Department of Health and Human Services and any office … of the U.S. Department of the Treasury or the U.S. Department of State and including, without limitation, the designation as a “specially designated national
8-K
EX-99.1
VERV
Verve Therapeutics Inc
29 Nov 23
Verve Therapeutics Announces Pricing of Public Offering of Common Stock and Concurrent Private Placement
4:54pm
LLC, Attention: Equity Syndicate Prospectus Department, 520 Madison Avenue, New York, NY 10022, or by telephone at (877) 821-7388, or by email … at Prospectus_Department@Jefferies.com; Guggenheim Securities, LLC, Attention: Equity Syndicate Department, 330 Madison Avenue, 8th Floor, New York, NY 10017
8-K
EX-1.1
cvwlpnmu
21 Jul 22
Verve Therapeutics Announces Pricing of Upsized Public Offering of Common Stock
4:46pm
8-K
EX-99.1
6wsb9b vso
21 Jul 22
Verve Therapeutics Announces Pricing of Upsized Public Offering of Common Stock
4:46pm
S-3
EX-1.2
s8ikpo4yu20
1 Jul 22
Shelf registration
4:36pm
10-K
77ioco7 on9kvp
14 Mar 22
Annual report
7:04am
10-K
EX-10.14
lwkh8wdi0
14 Mar 22
Annual report
7:04am